However, splenocytes from mice vaccinated with VSV-IFNß-Lcn2 generated a Th1-like, IFN-γ response to these tumor targets which was significantly greater than that generated by VSV-IFNß alone (Fig. 5E), suggesting that this TAA may be a potential HCCTAA in this system. The gene discussed is IFNG; the disease is neoplasm.